Related Experiment Video
Updated: Dec 11, 2025

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
IgA Nephropathy Associated with Trifluridine/Tipiracil: A Case Report
Geoffroy Desbuissons1,2, Liliane Ngango3, Isabelle Brochériou4
1Nephrology Department, Hôpital Privé de l'Ouest Parisien, Trappes, Ramsay Santé, Trappes, France, geodesbuissons@hotmail.fr.
Abstract:
Kidney diseases during chemotherapy treatment are variable, with different manifestations depending on the drugs used. Trifluridine/tipiracil is a treatment used in refractory metastatic digestive cancers. Its renal toxicity is poorly described. We report here the onset of a severe IgA nephropathy requiring hemodialysis which occurred several weeks after trifluridine/tipiracil treatment.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction
Acute Kidney Injury III: Clinical Manifestations
Nephrotic Syndrome I : Introduction

